{"listing":{"listing_type":"company","name":"Evolvere BioSciences","slug":"evolvere-biosciences","tagline":"Making Next-Generation Antibiotics that Outpace Bacterial Evolution","description":"🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. \n\n☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. \n\n🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️.\n\nWe are a team of biochemists and evolutionary biologists who met at the University of Oxford.\n\nEvolvere BioSciences is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://evolverebiosciences.com/","is_stealth":false,"normalized_domain":"evolverebiosciences.com","normalized_url_key":"evolverebiosciences.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/dd3489b7e5a5f2d3f7cc49de65917a83134da0a3.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/evolvere-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://evolverebiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://evolverebiosciences.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Artificial Intelligence","Biotech","Biotechnology"],"stage":null,"founded_year":null,"location":"Oxford, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:44:24.123Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","AI-powered Drug Discovery","Artificial Intelligence","Biotech","Therapeutics","Biotechnology"],"one_liner_for_search":"Evolvere BioSciences — Making Next-Generation Antibiotics that Outpace Bacterial Evolution (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 3","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:44:24.123Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"artificial-intelligence","name":"Artificial Intelligence","note":null,"profile_url":"/industries/artificial-intelligence"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}